| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |